ecNumber*7.6.2.2#specificActivity*-999#specificActivityMaximum*#commentary*#organism*Homo sapiens#literature*657840#!ecNumber*7.6.2.2#specificActivity*-999#specificActivityMaximum*#commentary*#organism*Bacillus subtilis#literature*658168#!ecNumber*7.6.2.2#specificActivity*-999#specificActivityMaximum*#commentary*#organism*Homo sapiens#literature*660546#!ecNumber*7.6.2.2#specificActivity*-999#specificActivityMaximum*#commentary*#organism*Homo sapiens#literature*695397#!ecNumber*7.6.2.2#specificActivity*-999#specificActivityMaximum*#commentary*activities of purified wild-type and mutant enzymes, overview#organism*Homo sapiens#literature*696343#!ecNumber*7.6.2.2#specificActivity*-999#specificActivityMaximum*#commentary*substrate specificities of transmembrane segment mutants, overview#organism*Candida albicans#literature*696431#!ecNumber*7.6.2.2#specificActivity*-999#specificActivityMaximum*#commentary*substrate specificity, overview#organism*Drosophila melanogaster#literature*696432#!ecNumber*7.6.2.2#specificActivity*-999#specificActivityMaximum*#commentary*relative drug resistance factor of wild-type MRP1and MRP3, and mutants, overview. Transport activities of wild-type MRP1 and of the mutant hybride MRP1/MRP3 prepared from Sf21 cells, overview#organism*Homo sapiens#literature*697583#!ecNumber*7.6.2.2#specificActivity*-999#specificActivityMaximum*#commentary*#organism*Homo sapiens#literature*699712#!ecNumber*7.6.2.2#specificActivity*-999#specificActivityMaximum*#commentary*#organism*Oryctolagus cuniculus#literature*699712#!ecNumber*7.6.2.2#specificActivity*-999#specificActivityMaximum*#commentary*#organism*Homo sapiens#literature*699752#!ecNumber*7.6.2.2#specificActivity*-999#specificActivityMaximum*#commentary*relative activities and substrate specificity of wild-type an dmutant enzymes#organism*Homo sapiens#literature*700297#!ecNumber*7.6.2.2#specificActivity*0.0197#specificActivityMaximum*#commentary*recombinant enzyme in resence of naringin, ATPase activity#organism*Homo sapiens#literature*701435#!ecNumber*7.6.2.2#specificActivity*0.02#specificActivityMaximum*#commentary*about, purified recombinant mutant F978C#organism*Homo sapiens#literature*696343#!ecNumber*7.6.2.2#specificActivity*0.0204#specificActivityMaximum*#commentary*recombinant enzyme, ATPase activity#organism*Homo sapiens#literature*701435#!ecNumber*7.6.2.2#specificActivity*0.0265#specificActivityMaximum*#commentary*recombinant enzyme in presence of verapamil and doxorubicin, ATPase activity#organism*Homo sapiens#literature*701435#!ecNumber*7.6.2.2#specificActivity*0.0268#specificActivityMaximum*#commentary*recombinant enzyme in presence of verapamil, ATPase activity#organism*Homo sapiens#literature*701435#!ecNumber*7.6.2.2#specificActivity*0.0289#specificActivityMaximum*#commentary*recombinant enzyme in presence of naringin and doxorubicin, ATPase activity#organism*Homo sapiens#literature*701435#!ecNumber*7.6.2.2#specificActivity*0.0386#specificActivityMaximum*#commentary*recombinant enzyme in presence of doxorubicin, ATPase activity#organism*Homo sapiens#literature*701435#!ecNumber*7.6.2.2#specificActivity*0.25#specificActivityMaximum*#commentary*purified recombinant wild-type enzyme#organism*Homo sapiens#literature*696343#!ecNumber*7.6.2.2#specificActivity*0.4#specificActivityMaximum*#commentary*22&deg;C, pH 7.4#organism*Helicoverpa armigera#literature*711295#!ecNumber*7.6.2.2#specificActivity*0.5#specificActivityMaximum*#commentary*purified recombinant mutant A980C#organism*Homo sapiens#literature*696343#!ecNumber*7.6.2.2#specificActivity*1.2#specificActivityMaximum*#commentary*pH 8, 37&deg;C, 8-aza-ATPase activity#organism*Bacillus subtilis#literature*659277#!ecNumber*7.6.2.2#specificActivity*1.35#specificActivityMaximum*1.5#commentary*purified wild-type BmrA#organism*Bacillus subtilis#literature*696248#!ecNumber*7.6.2.2#specificActivity*1.7#specificActivityMaximum*#commentary*purified recombinant wild-type MDR1, ATPase activity with substrate verapamil#organism*Homo sapiens#literature*701069#!ecNumber*7.6.2.2#specificActivity*3.5#specificActivityMaximum*#commentary*with verapamil and ATP as substrates, at pH 7.4 and 37&deg;C#organism*Homo sapiens#literature*733539#!ecNumber*7.6.2.2#specificActivity*6.5#specificActivityMaximum*#commentary*pH 8, 37&deg;C, ATPase activity#organism*Bacillus subtilis#literature*659277#!ecNumber*7.6.2.2#specificActivity*7#specificActivityMaximum*#commentary*37&deg;C, recombinant YvcC, ATPase activity#organism*Bacillus subtilis#literature*658086#!ecNumber*7.6.2.2#specificActivity*270#specificActivityMaximum*#commentary*wild-type, substrate methotrexate, pH 7.5, 37&deg;C#organism*Homo sapiens#literature*718806#!ecNumber*7.6.2.2#specificActivity*580#specificActivityMaximum*#commentary*wild-type, substrate estradiol 17-beta-D-glucuronide, pH 7.5, 37&deg;C#organism*Homo sapiens#literature*718806#!ecNumber*7.6.2.2#specificActivity*650#specificActivityMaximum*#commentary*wild-type, substrate folic acid, pH 7.5, 37&deg;C#organism*Homo sapiens#literature*718806#!ecNumber*7.6.2.2#specificActivity*3500#specificActivityMaximum*#commentary*wild-type, substrate cyclic guanosine monophosphate, pH 7.5, 37&deg;C#organism*Homo sapiens#literature*718806#